Luc Haasbroek is a writer and videographer from Durban, South Africa. He has been writing professionally about pop culture for eight years. Luc's areas of interest are broad: he's just as passionate ...

On September 22, the Sun will cross the celestial equator and mark the beginning of a new season and the September 2021 fall equinox. For that brief moment during the autumn equinox, night and day are ...

After a year of production delays and extended hiatuses, TV did return in 2021 with a vengeance—and a vision, and a mission, and even another look at one of our favorite terrible families. Though ...

As of April, the pace of inflation has slowed from a year-over-year peak of 9.1% to 5%. That's good news for struggling consumers, but doesn't tell the whole story of how much more Americans are ...

Economic prospects have diverged further across countries since the April 2021 World Economic Outlook (WEO) forecast. Vaccine access has emerged as the principal fault line along which the global ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Traditional caching fails to stop "thundering ...

2021 was another remarkable and demanding year for the Transparency International movement. As the pandemic continued to disrupt and reshape global affairs, our international secretariat, chapters and ...

The COVID-19 pandemic set off nearly unprecedented churn in the U.S. labor market. Widespread job losses in the early months of the pandemic gave way to tight labor markets in 2021, driven in part by ...

Music contains so many multitudes that sweeping generalizations about it rarely ring true, but this one still does: There are few things more exciting than an excellent debut album. It’s a thrill to ...

After a hectic 2020 filing season, the 2021 season appears to be returning to the norm: The deadline to file 2021 federal taxes for most people is Monday, April 18, the IRS announced Monday, as April ...

The FDA’s approval count last year was in line with recent trends, despite the continued impact of COVID-19. The agency’s Center for Drug Evaluation and Research (CDER) approved 50 novel therapeutics ...